APLMW vs. ATNFW, SXTPW, DRTSW, BCDAW, BCTXW, CDIOW, CTCXW, SAVAW, CELUW, and CEROW
Should you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Cassava Sciences (SAVAW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.
Apollomics (NASDAQ:APLMW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking and media sentiment.
In the previous week, Apollomics and Apollomics both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 beat Apollomics' score of 1.87 indicating that 180 Life Sciences is being referred to more favorably in the news media.
Apollomics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Summary
180 Life Sciences beats Apollomics on 1 of the 1 factors compared between the two stocks.
Get Apollomics News Delivered to You Automatically
Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
APLMW vs. The Competition
Apollomics Competitors List
Related Companies and Tools
